Arcus Biosciences RCUS
NYSE RCUS
$25.73 -0.10 (-0.39%)
As of: Oct 1, 2026 · 12:49 PM EDT

Arcus Biosciences (RCUS) Other Operating Expenses (2020 - 2024)

Updated

Arcus Biosciences (RCUS) reported Other Operating Expenses of $20 million for FY2024.

Analysis

Arcus Biosciences (RCUS) Other Operating Expenses (2020 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Arcus Biosciences 3.28 Bn -53.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 20.00 Mn
Dec 31, 2020 -248,000.00
API Access

Arcus Biosciences Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=RCUS&period=max&api_key=YOUR_API_KEY